Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

被引：0

作者：

Hamadeh, Issam ^{[1
]}

Shekarkhand, Tala ^{[1
]}

Rueda, Colin ^{[1
]}

Firestone, Ross ^{[1
]}

Wang, Alice ^{[1
]}

Korde, Neha ^{[1
]}

Hultcrantz, Malin ^{[1
]}

Lesokhin, Alexander ^{[1
]}

Mailankody, Sham ^{[1
]}

Hassoun, Hani ^{[1
]}

Shah, Urvi ^{[1
]}

Maclachlan, Kylee ^{[1
]}

Patel, Dhwani ^{[1
]}

Shah, Gunjan ^{[1
]}

Scordo, Michael ^{[1
]}

Lahoud, Oscar ^{[1
]}

Chung, David ^{[1
]}

Landau, Heather ^{[1
]}

Giralt, Sergio ^{[1
]}

Usmani, Saad ^{[1
]}

Tan, Carlyn Rose ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-013

引用

页码：S40 / S40

页数：1

共 50 条

[21] CAR plus T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma
Harrison, Simon J.
Nguyen, Tamia
Rahman, Marzia
Er, Jeremy
Li, Jessica
Li, Katherine
Lendvai, Nikoletta
Schecter, Jordan M.
Banerjee, Arnob
Roccia, Tito
Foulk, Brad
Gu, Junchen
Zhao, Hao
Smirnov, Denis
Slaughter, Ana
Lonardi, Carolina
Lee, Erin
Marquez, Loreta
Jadidi, Shirin
Costa Filho, Octavio
Patel, Nitin
Geng, Dong
Haynes, Nicole M.
Kelly, Hannah
Lade, Stephen
Grimmond, Sean
Blombery, Piers
BLOOD, 2023, 142
[22] Frailty and Outcomes after Bispecific T-Cell Engager Therapy for Patients with Relapsed/Refractory Multiple Myeloma
Adegbite, Benjamin O.
Tan, Carlyn Rose
Shekarkhand, Tala
Firestone, Ross S.
Jurgens, Eric M.
Miller, Kevin
Lesokhin, Alexander M.
Shah, Gunjan L.
Korde, Neha
Rajeeve, Sridevi
Chung, David J.
Landau, Heather J.
Scordo, Michael
Hassoun, Hani
Maclachlan, Kylee H.
Shah, Urvi A.
Hultcrantz, Malin
Hamadeh, Issam S.
Giralt, Sergio
Mailankody, Sham
Usmani, Saad Z.
Hashmi, Hamza
BLOOD, 2024, 144 : 4735 - 4736
[23] Laryngeal edema as a symptom of local cytokine release syndrome after BCMA-targeting CAR-T therapy for relapsed and refractory multiple myeloma
Nakanishi, Yoko
Marumo, Yoshiaki
Ri, Masaki
Kinoshita, Shiori
Suzuki, Tomotaka
Narita, Tomoko
Kusumoto, Shigeru
Komatsu, Hirokazu
Iida, Shinsuke
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (05) : 647 - 651
[24] NK cell therapy in relapsed refractory multiple myeloma
Roshandel, Elham
Ghaffari-Nazari, Haniyeh
Mohammadian, Mozhdeh
Salimi, Maryam
Abroun, Saeid
Mirfakhraie, Reza
Hajifathali, Abbas
CLINICAL IMMUNOLOGY, 2023, 246
[25] Laryngeal edema as a symptom of local cytokine release syndrome after BCMA-targeting CAR-T therapy for relapsed and refractory multiple myeloma
Yoko Nakanishi
Yoshiaki Marumo
Masaki Ri
Shiori Kinoshita
Tomotaka Suzuki
Tomoko Narita
Shigeru Kusumoto
Hirokazu Komatsu
Shinsuke Iida
International Journal of Hematology, 2023, 118 : 647 - 651
[26] Effect of talquetamab on responses in patients with relapsed and refractory multiple myeloma with prior exposure to T-cell directed therapies.
Graeter, Allison
Alexis, Omar
Puglianini, Castaneda
Hansen, Doris K.
Vazquez-Martinez, Mariola A.
Blue, Brandon Jamaal
Khadka, Sushmita
Liu, Hien
Ochoa-Bayona, Jose L.
Freeman, Ciara L.
Locke, Frederick L.
Nishihori, Taiga
Shain, Kenneth H.
Baz, Rachid C.
Alsina, Melissa
Grajales-Cruz, Ariel Felipe
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[27] A randomized phase II study of xcellerated T cells™ with or without prior fludarabine therapy in patients with relapsed or refractory multiple myeloma
Berenson, JR
Borrello, IM
Vij, R
Bashey, A
Martin, T
Boccia, RV
Mohrbacher, A
Simic, A
Spitzer, G
Meyer, J
Berenson, RJ
Frohlich, MW
BLOOD, 2004, 104 (11) : 662A - 663A
[28] Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment
Hujun Li
Lingling Yin
Ying Wang
Xiangmin Wang
Ming Shi
Jiang Cao
Zhiling Yan
Wei Sang
Hai Cheng
Feng Zhu
Haiying Sun
Depeng Li
Guangjun Jing
Junnian Zheng
Zhenyu Li
Kailin Xu
Bone Marrow Transplantation, 2020, 55 : 2215 - 2218
[29] Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma
Chen, Wei
Wang, Ying
Qi, Kunming
Shi, Ming
Cao, Jiang
Bhansali, Rahul
Wang, Xue
Liu, Yang
Li, Hujun
Zhang, Huanxin
Yan, Zhiling
Sang, Wei
Cheng, Hai
Zhu, Feng
Sun, Haiying
Li, Depeng
Jing, Guangjun
Zheng, Junnian
Li, Zhenyu
Xu, Kailin
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 273.e1 - 273.e5
[30] Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment
Sidana, Surbhi
Peres, Lauren C.
Hashmi, Hamza
Hosoya, Hitomi
Ferreri, Christopher
Khouri, Jack
Dima, Danai
Atrash, Shebli
Voorhees, Peter
Simmons, Gary
Sborov, Douglas W.
Kalariya, Nilesh
Hovanky, Vanna
Bharadwaj, Sushma
Miklos, David
Wagner, Charlotte
Kocoglu, Mehmet H.
Kaur, Gurbakhash
Davis, James A.
Midha, Shonali
Janakiram, Murali
Freeman, Ciara
Alsina, Melissa
Locke, Frederick
Gonzalez, Rebecca
Lin, Yi
Mcguirk, Joseph
Afrough, Aimaz
Shune, Leyla
Patel, Krina K.
Hansen, Doris K.
HAEMATOLOGICA, 2024, 109 (03) : 777 - 786

← 1 2 3 4 5 →